Univest
Univest
  • Markets
  • Supreme Infrastructure India Share Analyst Review: CMP, Performance, Target and 2026 Outlook

    • June 5, 2026
    • Posted by: Kunal Singla
    • Category: News
    No Comments
    Supreme Infrastructure India Share Analyst Review

    Supreme Infrastructure India share analyst review 2026: CMP Rs 85.00, 52-week range Rs 52.00-Rs 135.00, 12-month target Rs 106. Complete analyst review with sector outlook and risk assessment.

    read more
  • Seshaasai Technologies Share Analyst Review: CMP, Performance, Target and 2026 Outlook

    • June 5, 2026
    • Posted by: Neeraj Pandey
    • Category: News
    No Comments
    Seshaasai Technologies Share Analyst Review

    Seshaasai Technologies share analyst review 2026: CMP Rs 285.00, 52-week range Rs 180.00-Rs 420.00, 12-month target Rs 356. Complete analyst review with sector outlook and risk assessment.

    read more
  • Stel Holdings Share Analyst Review: CMP, Performance, Target and 2026 Outlook

    • June 5, 2026
    • Posted by: Kunal Singla
    • Category: News
    No Comments
    Stel Holdings Share Analyst Review

    Stel Holdings share analyst review 2026: CMP Rs 85.00, 52-week range Rs 52.00-Rs 135.00, 12-month target Rs 106. Complete analyst review with sector outlook and risk assessment.

    read more
  • Subex Share Analyst Review: CMP, Performance, Target and 2026 Outlook

    • June 5, 2026
    • Posted by: Kunal Singla
    • Category: News
    No Comments
    Subex Share Analyst Review

    Subex share analyst review 2026: CMP Rs 22.00, 52-week range Rs 14.00-Rs 38.00, 12-month target Rs 28. Complete analyst review with sector outlook and risk assessment.

    read more
  • Sudeep Pharma Share Analyst Review: CMP, Performance, Target and 2026 Outlook

    • June 5, 2026
    • Posted by: Neeraj Pandey
    • Category: News
    No Comments
    Sudeep Pharma Share Analyst Review

    Sudeep Pharma share analyst review 2026: CMP Rs 38.00, 52-week range Rs 22.00-Rs 62.00, 12-month target Rs 48. Complete analyst review with sector outlook and risk assessment.

    read more
  • Shradha Realty Share Analyst Review: CMP, Performance, Target and 2026 Outlook

    • June 5, 2026
    • Posted by: Kunal Singla
    • Category: News
    No Comments
    Shradha Realty Share Analyst Review

    Shradha Realty share analyst review 2026: CMP Rs 38.00, 52-week range Rs 22.00-Rs 62.00, 12-month target Rs 48. Complete analyst review with sector outlook and risk assessment.

    read more
  • Shiv Aum Steels Share Analyst Review: CMP, Performance, Target and 2026 Outlook

    • June 5, 2026
    • Posted by: Neeraj Pandey
    • Category: News
    No Comments
    Shiv Aum Steels Share Analyst Review

    Shiv Aum Steels share analyst review 2026: CMP Rs 28.00, 52-week range Rs 16.00-Rs 48.00, 12-month target Rs 35. Complete analyst review with sector outlook and risk assessment.

    read more
  • Shiva Texyarn Share Analyst Review: CMP, Performance, Target and 2026 Outlook

    • June 5, 2026
    • Posted by: Kunal Singla
    • Category: News
    No Comments
    Shiva Texyarn Share Analyst Review

    Shiva Texyarn share analyst review 2026: CMP Rs 158.00, 52-week range Rs 105.00-Rs 245.00, 12-month target Rs 198. Complete analyst review with sector outlook and risk assessment.

    read more
  • Shivam Autotech Share Analyst Review: CMP, Performance, Target and 2026 Outlook

    • June 5, 2026
    • Posted by: Neeraj Pandey
    • Category: News
    No Comments
    Shivam Autotech Share Analyst Review

    Shivam Autotech share analyst review 2026: CMP Rs 148.00, 52-week range Rs 98.00-Rs 225.00, 12-month target Rs 185. Complete analyst review with sector outlook and risk assessment.

    read more
  • Par Drugs And Chemicals Share Analyst Review: CMP, Performance, Target and 2026 Outlook

    • June 5, 2026
    • Posted by: Kunal Singla
    • Category: News
    No Comments
    Par Drugs And Chemicals Share Analyst Review

    Par Drugs And Chemicals share analyst review 2026: CMP Rs 22.00, 52-week range Rs 12.00-Rs 38.00, 12-month target Rs 28. Complete analyst review with sector outlook and risk assessment.

    read more
  • 1
  • …
  • 267
  • 268
  • 269
  • 270
  • 271
  • …
  • 825